All Stories

  1. Tegoprazan: a novel, highly selective, and potent potassium-competitive acid blocker (P-CAB)
  2. Non-Blood Contact Left Ventricular Assist Devices
  3. Molecular Epidemiological Analysis of SARS-CoV
  4. Therapeutic Effects of Cortex Phellodendri, Epimedium brevicornu, and Earthworm on Chronic Prostatitis/Chronic Pelvic Pain Syndrome Mice
  5. The Underlying Effect of Urate Levels on Female Infertility
  6. Astrocyte involvement in metabolic regulation and disease
  7. Naringin: Cardioprotective properties and safety profile in diabetes treatment
  8. Promising phytopharmacology, nutritional potential, health benefits, and traditional usage of Tribulus terrestris L. herb
  9. Benzimidazole Derivative (N-{4-[2-(4-Methoxyphenyl)-1H-Benzimidazole-1-Sulfonyl] Phenyl} Acetamide) Ameliorates Methotrexate-Induced Intestinal Mucositis by Suppressing Oxidative Stress and Inflammatory Markers in Mice
  10. Circadian neurogenetics and its implications in neurophysiology, behavior, and chronomedicine
  11. Cigarette smoking and air pollution exposure and their effects on cardiovascular diseases
  12. The Antihypertensive Guanabenz Exacerbates Integrated Stress Response and Disrupts the Brain Circadian Clock
  13. Current Updates on the Role of MicroRNA in the Diagnosis and Treatment of Neurodegenerative Diseases
  14. The severity of COVID-19 in hypertensive patients is associated with mirSNPs in the 3′ UTR of ACE2 that associate with miR-3658: In silico and in vitro studies
  15. Curative potential of Populus ciliata Wall ex. Royle extract against adjuvant-induced arthritis and peripheral neuropathy in Wistar rats
  16. Assessment of Antioxidant, Antimicrobial, and Acute Toxicology Profiles of Cordia rothii and Viola serpens
  17. Simple methods of dissection protocols for the rapid isolation of rat dorsal root ganglia under the non-microscopic condition
  18. Association of obesity and cardiovascular disease and progress in pharmacotherapy: what is next for obesity?
  19. Agomelatine: An Astounding Sui-generis Antidepressant?
  20. Determinants of Voluntary Counseling and Testing Service Uptake Among Adult Sub-Saharan Africans: A Systematic Review and Meta-Analysis
  21. Polycyclic aromatic hydrocarbon and its effects on human health: An overeview
  22. Effects of pretreatment of ethanolic extract of Siegesbeckia pubescens Makino on cerebral ischemia in rats
  23. Cardioprotective effect of silicon-built restraint device (ASD), for left ventricular remodeling in rat heart failure model
  24. Natural polysaccharide-based biodegradable polymeric platforms for transdermal drug delivery system: a critical analysis
  25. Multifunctional mesoporous silica-based nanocomposites: Synthesis and biomedical applications
  26. A critical analysis of SARS-CoV-2 (COVID-19) complexities, emerging variants, and therapeutic interventions and vaccination strategies
  27. Therapeutic interventions to urologic chronic pelvic pain syndrome and UPOINT system for clinical phenotyping: How far are we?
  28. Association of urinary polycyclic aromatic hydrocarbon metabolites and cardiovascular disease among US population: National Health and Nutrition Examination Surveys (NHANES): A cross-sectional study
  29. Resveratrol (RV): A pharmacological review and call for further research
  30. Subclavian steal syndrome associated with Sjogren's syndrome: A case report
  31. Abnormal expression profile of plasma-derived exosomal microRNAs in patients with treatment-resistant depression
  32. Effects of coenzyme Q10 supplementation on statin-induced myopathy: a meta-analysis of randomized controlled trials
  33. Investigation of the relationships between sleep behaviors and risk of healthspan termination: a prospective cohort study based on 323,373 UK-Biobank participants
  34. Emerging mechanisms of valproic acid-induced neurotoxic events in autism and its implications for pharmacological treatment
  35. A Novel Method for Automatic Pharmacological Evaluation of Sucrose Preference Change in Depression Mice
  36. New Application of an Old Drug Proparacaine in Treating Epilepsy via Liposomal Hydrogel Formulation
  37. Therapeutic approach for global myocardial injury using bone marrow-derived mesenchymal stem cells by cardiac support device in rats
  38. Biotechnological approaches to the production of plant-derived promising anticancer agents: An update and overview
  39. Drinking-water nitrate and cancer risk: A systematic review and meta-analysis
  40. Autism spectrum disorder (ASD): Disturbance of the melatonin system and its implications
  41. The Relevance of SNPs at 3′UTR Region of CASP7 and miR-371b-5p Associated Diseases: A Computational Analysis
  42. Recent advances in cardiac targeted drug delivery: from theory to practice
  43. Pharmacokinetic Advantage of ASD Device Promote Drug Absorption through the Epicardium
  44. Role of Polycyclic Aromatic Hydrocarbons as EDCs in Metabolic Disorders
  45. Physiology of Endocrine System and Related Metabolic Disorders
  46. A review on structure, extraction, and biological activities of polysaccharides isolated from Cyclocarya paliurus (Batalin) Iljinskaja
  47. Gut-brain axis: A matter of concern in neuropsychiatric disorders…!
  48. Targeting folate receptors (α1) to internalize the bleomycin loaded DNA-nanotubes into prostate cancer xenograft CWR22R cells
  49. Factors Influencing Sleep Quality and Effects of Sleep on Hypertension
  50. TRPM8 channels: A review of distribution and clinical role
  51. PAM8 SUPPRESSION OF TGP ON MYOCARDIAL REMODELING BY REGULATING THE NF-KB PATHWAY
  52. Synthesis of Ligand Functionalized ErbB-3 Targeted Novel DNA Nano-Threads Loaded with the Low Dose of Doxorubicin for Efficient In Vitro Evaluation of the Resistant Anti-Cancer Activity
  53. Systemic and local delivery of mesenchymal stem cells for heart renovation: Challenges and innovations
  54. Synthetic NRG-1 functionalized DNA nanospindels towards HER2/neu targets for in vitro anti-cancer activity assessment against breast cancer MCF-7 cells
  55. A Review of Medicinal Plants in Cardiovascular Disorders: Benefits and Risks
  56. Quality of life after dual kidney transplant
  57. Expression of inflammatory mediators in murine models of CP/CPPS induced by T2 antigen
  58. Mitochondrial-dependent apoptosis is associated with the Drp1 activation
  59. β-Adrenergic receptor, an essential target in cardiovascular diseases
  60. Evaluation of chitosan/eudragit hybrid coating over cubic DNA nanospheres with superior stability and therapeutic outcomes
  61. Interventions to CP/CPPS treatment. Where are we standing and what's next?
  62. An epicardial delivery of nitroglycerine by ASD device improves cardiac function in a rat model
  63. PLL-alginate and the HPMC-EC hybrid coating over the 3D DNA nanocubes as compact nanoparticles for oral administration
  64. Cerebrovascular inflammation: A critical trigger for neurovascular injury?
  65. Correction to: The impact of clinical pharmacy services in Nepal in the context of current health policy: a systematic review
  66. DNA scaffold nanoparticles coated with HPMC/EC for oral delivery
  67. Chitosan-coated rectangular DNA nanospheres for better outcomes of anti-diabetic drug
  68. DNA nano-cubes as a core material protected by the alginate coating for anti-diabetic drug.
  69. A cardiac troponin I study in a minimally invasive myocardial infarction canine model
  70. The impact of clinical pharmacy services in Nepal in the context of current health policy: a systematic review
  71. In-vitro Pre-Treatment of Cancer Cells with TGF-β1
  72. Potential nutraceutical properties and risks of coffee
  73. Chitosan oligosaccharide (COS): An overview
  74. Drp1-associated mitochondrial dysfunction and mitophagy: a novel mechanism in hepatotoxicity
  75. Suppression of TGP on myocardial remodeling by regulating the NF-κB pathway
  76. Experimental rodent models of chronic prostatitis and evaluation criteria
  77. Phytocosmeceutical formulation development, characterization and its in-vivo investigations
  78. Oxidative stress in CP/CPPS, male infertility and antioxidant function cope oxidative stress
  79. The Promising Therapeutic Applications of Pomegranate (Punica Granatum L.) as a Functional Food
  80. Clinical evaluation of cancer biomarkers in advanced stage gastric cancer
  81. Chitooligosaccharide physicochemical and biological properties with thermal degradation products
  82. Cardio-supportive devices (VRD & DCC device) and patches for advanced heart failure
  83. ASD device delivers bone marrow stem cells to epicardium has promising effects in advanced HF
  84. Pharmacological values and therapeutic properties of black tea ( Camellia sinensis L.)
  85. The promising future of ventricular restraint therapy for the management of end-stage heart failure
  86. Chlorogenic acid (CGA): A pharmacological review and call for further research
  87. Pharmacological effects and potential therapeutic targets of DT-13
  88. Green tea (Camellia sinensis L.) and L-theanine: Medicinal values and beneficial health applications
  89. Gastric cancer biomarkers in prognosis and pre- and post- chemotherapy in clinical practice
  90. A novel ASD device deliver Salvia miltiorrhiza to epicardium have good curative effects in HF
  91. Clinical Evaluation of CEA , CA125, CA19-9 and CA72-4 In Gastric Cancer Patients With Adjuvant Chemotherapy
  92. Phytochemistry, Modes of Action and Beneficial Health Applications of Green Tea (Camellia sinensis) in Humans and Animals
  93. 22nd International Abstracts Book
  94. Chicory (Cichorium intybus) Herb: Chemical Composition, Pharmacology, Nutritional and Healthical Applications